Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Price:
2.75
USD
-0.36%
Market Closed
Market Cap:
$166.6m
Cash Flow Statement
Cash Flow Statement
Acumen Pharmaceuticals Inc
Acumen Pharmaceuticals Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(7)
|
(32)
|
(92)
|
(93)
|
(101)
|
(83)
|
(32)
|
(38)
|
(43)
|
(45)
|
(47)
|
(49)
|
(52)
|
(56)
|
(65)
|
(82)
|
(102)
|
(116)
|
(137)
|
(133)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
4
|
5
|
5
|
6
|
7
|
8
|
9
|
10
|
10
|
10
|
10
|
|
| Other Non-Cash Items |
(0)
|
23
|
81
|
81
|
82
|
60
|
3
|
3
|
4
|
4
|
4
|
4
|
5
|
5
|
4
|
5
|
4
|
5
|
8
|
10
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
|
| Change in Working Capital |
0
|
1
|
(0)
|
(5)
|
0
|
(1)
|
3
|
7
|
4
|
4
|
(0)
|
(1)
|
4
|
(0)
|
5
|
9
|
12
|
8
|
11
|
0
|
|
| Cash from Operating Activities |
(7)
N/A
|
(8)
-7%
|
(11)
-35%
|
(17)
-60%
|
(18)
-5%
|
(24)
-33%
|
(26)
-9%
|
(28)
-6%
|
(35)
-27%
|
(37)
-5%
|
(42)
-14%
|
(46)
-9%
|
(43)
+6%
|
(51)
-18%
|
(55)
-9%
|
(67)
-22%
|
(86)
-28%
|
(102)
-19%
|
(118)
-15%
|
(124)
-5%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
(94)
|
(104)
|
(109)
|
(100)
|
50
|
39
|
3
|
5
|
(143)
|
(172)
|
(139)
|
(112)
|
(30)
|
48
|
86
|
86
|
137
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
(0)
N/A
|
(94)
-941 000%
|
(104)
-11%
|
(109)
-5%
|
(100)
+8%
|
50
N/A
|
39
-21%
|
2
-94%
|
5
+97%
|
(143)
N/A
|
(172)
-20%
|
(139)
+19%
|
(113)
+19%
|
(30)
+73%
|
48
N/A
|
86
+79%
|
87
+1%
|
137
+58%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
45
|
45
|
77
|
245
|
200
|
0
|
169
|
0
|
4
|
0
|
4
|
127
|
122
|
130
|
130
|
8
|
8
|
(0)
|
(0)
|
(0)
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
0
|
29
|
(1)
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
0
|
|
| Cash from Financing Activities |
45
N/A
|
45
N/A
|
76
+71%
|
245
+221%
|
200
-18%
|
0
N/A
|
169
N/A
|
(0)
N/A
|
4
N/A
|
0
N/A
|
4
N/A
|
127
+3 264%
|
152
+20%
|
159
+5%
|
159
+0%
|
36
-77%
|
7
-81%
|
(0)
N/A
|
(0)
+60%
|
(0)
+49%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
37
N/A
|
37
-1%
|
66
+79%
|
134
+104%
|
78
-41%
|
67
-14%
|
42
-37%
|
22
-49%
|
8
-63%
|
(31)
N/A
|
(34)
-10%
|
(62)
-85%
|
(63)
-1%
|
(31)
+51%
|
(9)
+70%
|
(62)
-575%
|
(31)
+49%
|
(17)
+47%
|
(31)
-87%
|
14
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(8)
-7%
|
(11)
-35%
|
(17)
-59%
|
(18)
-5%
|
(24)
-33%
|
(26)
-9%
|
(28)
-6%
|
(35)
-27%
|
(37)
-5%
|
(42)
-14%
|
(46)
-9%
|
(43)
+6%
|
(51)
-18%
|
(55)
-9%
|
(67)
-22%
|
(86)
-28%
|
(102)
-19%
|
(118)
-15%
|
(124)
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
